Delivery Order SPE2DR25D1202-SPE2DR26F72HM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL in 200 mL units) with a ceiling value of $20,075.28. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of November 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL, 200 mL units) with a ceiling value of $5,149.90. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities, with a firm fixed price ceiling value of $1,908.72. The contract, which is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ropivacaine 0.2% in 400 mg/200 mL vials with a ceiling value of $1,431.54. This is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive set-aside contract. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units, with a contract ceiling value of $6,988.89. This is a firm fixed price delivery order with an ultimate completion date of October 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units) at a ceiling value of $1,431.54. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is performed out of the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $3,428.19 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This firm fixed-price delivery order is scheduled for completion by June 20, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting the vendor's established capability to...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a $2,477.82 delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml), a local anesthetic pharmaceutical product. This firm fixed price contract, with an ultimate completion date of June 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml units, with a ceiling value of $2,147.31. This competitively awarded, firm fixed-price delivery order is set to be completed by September 19, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72HMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units at a firm fixed price of $4,058.09. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The work is scheduled for completion by November 19, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. Ropivacaine is a local anesthetic commonly used in medical and surgical procedures. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems. This delivery order exemplifies the company's critical role in the DLA Medical Supply Chain, fulfilling specific pharmaceutical requirements for Defense Health Agency, U.S. Coast Guard, and other government healthcare customers through the flexible Pharmaceutical Prime Vendor Global Program framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/18/25 |